Haemophilus influenzae type b-specific antibody in infants after maternal immunization

Pediatric Infectious Disease Journal

Volumn 16, Issue 12, 1997, Pages 1122-1130

  Englund, Janet A ^a   Glezen, W Paul ^a   Thompson, Claudette ^b   Anwaruddin, Raana ^b   Turner, Connie S ^a   Siber, George R ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PFIZER INC   (United States)

Author keywords

Antibody in infants; Haemophilus influenzae; Maternal immunization

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HIBIMMUNE; PHOSPHATE; RIBITOL; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; HUMAN; INFANT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MATERNAL CARE; NEWBORN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THIRD TRIMESTER PREGNANCY;

ANTIBODIES, BACTERIAL; FEMALE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; INFANT; PENTOSEPHOSPHATES; POLYSACCHARIDES, BACTERIAL; PREGNANCY;

EID: 0031453960     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199712000-00005     Document Type: Article

References (39)

1. Amstey MS, Insel RA, Munoz J, Pichichero ME. Fetal-neonatal passive immunization against Hemophilus influenzae type b. Am J Obstet Gynecol 1985;153:607-11.
2. Glezen WP, Englund JA, Siber GR, et al. Maternal immunization with the capsular polysaccharide vaccine for Hemophilus influenzae type b. J Infect Dis 1992;165(Suppl):S134-6.
3. Englund JA, Glezen WP, Turner C, Harvey J, Siber GR. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Hemophilus influenzae type b vaccines. J Infect Dis 1995;171:99-105.
4. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N Engl J Med 1988;319:1180-5.2.
5. Santosham M, Reid R, Ambrosino DM, et al. Prevention of Hemophilus influenzae type b infections in high risk infants treated with bacterial polysaccharide immunoglobulin. N Engl J Med 1987;317:923-9.
6. Edwards KM, Meade BD, Decker MD, et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics (Suppl) 1995;96:548-56.
7. American Academy of Pediatrics, Committee on Infectious Diseases. Hemophilus influenzae type b conjugate vaccines: immunization of children 2 to 15 months of age. Pediatrics 1991;88:169-72.
8. Ambrosino DM, Schiffman G, Gotshlich EC, et al. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest 1985;75:1935-42.
9. Zollinger WD, Boslego JW. A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. J Immunol Methods 1981;46:129-40.
10. Mulholland EK, Suara RO, Siber G, et al. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. JAMA 1996;275:1181-8.
11. Alper CA. Plasma protein measurements as a diagnostic aid. N Engl J Med 1974;291:287-90.
12. Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1984;149:1034-5.
13. Insel RA, Anderson P, Pichichero ME, Amstey MS, Ekborg G, Smith DH. Anticapsular antibody to Hemophilus influenzae type b. In: Sell SH, Wright PF, eds. Hemophilus influenzae, 1982. New York: Elsevier, 1982:155-68.
14. Bijlmer HA, van Alphen L, Greenwood BM, et al. The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa. J Infect Dis 1990;161:1210-15.
15. Insel RA, Anderson PW. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants. J Exp Med 1986;163:262-9.
16. Scott MG, Crimmins DL, McCourt DW, et al. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. J Immunol 1991; 147:4007-13.
17. Insel RA, Amstey M, Woodin K, Pichichero M. Maternal immunization to prevent infectious diseases in the neonate or infant. Int J Technol Assess Health Care 1994;10:143-53.
18. Adderson EE, Shackelford PG, Quinn A, Wilson PA, Carroll WL. Diversity of immunoglobulin light chain usage in the human immune response to Hemophilus influenzae type b capsular polysaccharide. Pediatr Res 1993;33:307-11.
19. Insel RA, Adderson EE, Carroll WL. The repertoire of human antibody to the Hemophilus influenzae type b capsular polysaccharide. Int Rev Immunol 1992;9:25-43.
20. Park MK, Englund JA, Glezen WP, Siber GR, Nahm MR. Association of placental transfer of anti-Haemophilus influenzae type b polysaccharide antibodies with their V regions. Vaccine 1996;14:1219-22.
21. Einhorn MS, Granoff DM, Nahm MH, Quinn A, Shackelford PG. Concentrations of antibodies in paired maternal and infant sera: relationship to IgG subclass. J Pediatr 1987;111:783-8.
22. Carvalho A, Giampaglia C, Kimura H, et al. Maternal and infant antibody response to meningococcal vaccination in pregnancy. Lancet 1977;2:809-11.
23. McCormick JB, Gussmao HH, Nakumura S, et al. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born to mothers vaccinated during pregnancy. J Clin Invest 1980;65:1141-4.
24. O'Dempsey TJD, McArdle T, Ceesay SJ, et al. Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy. Vaccine 1996;14:963-70.
25. Gill TJ III, Repetti CF, Metlay LA, et al. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 1983;72:987-96.
26. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993;168:647-56.
27. Gill TJ III, Karasic RB, Antoncic J, Rabin BS. Long-term follow-up of children born to women immunized with tetanus toxoid during pregnancy. Am J Reprod Immunol 1991;25:69-71.
28. Linder N, Ohel G. In utero vaccination. Clin Perinatol 1994; 21:663-74.
29. Englund JA, WP Glezen. Maternal immunization for the prevention of infection in early infancy. Semin Pediatr Infect Dis 1991;2:225-31.
30. Letson GW, Santosham M, Reid R, et al. Comparison of active and combined passive/active immunization of Navajo children against Hemophilus influenzae type b. Pediatr Infect Dis J 1988;7:747-52.
31. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenze type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
32. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Hemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;64:982-6.
33. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine J Pediatr 1993;122:517-23.
34. Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
35. Gray BM, Converse GM III, Dillon HC Jr. Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine. J Clin Microbiol 1983;18:1102-7.
36. Lucas AH, Langley RJ, Granoff DM, Nahm MH, Kitamura MY, Scott MG. An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide. J Clin Invest 1991; 88:1811-8.
37. Granoff DM, Shackelford PG, Holmes SJ, The Collaborative Vaccine Study Group, Lucas AH. Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. J Clin Invest 1993;91:788-96.
38. Stein KE, Soderstrom. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med 1984;160:1001-11.
39. Eloi-Santos SM, Novato-Silva E, Maselli VM, Gazzinelli G, Colley DG, Correa-Oliveira R. Idiotypic sensitization in utero of children born to mothers with schistosomiasis or Chagas' disease. J Clin Invest 1989;84:1028-31.